Work

66eP Hunting for blood-based biomarkers for immunotherapy optimization in lung cancer

Year: 2025

Type: article

Abstract: In the battle against the world’s deadliest cancer, lung cancer, immuno-oncology (IO) treatments have increased the survival of many patients. However, treatment resistance remains the most common outcome. This study aims to address this issue by examining the peripheral immune response in Non-Small Cell Lung Cancer (NSCLC) patients undergoing IO treatment.

Source: Immuno-Oncology Technology

DOI: 10.1016/j.iotech.2025.101149